Tracking Symptoms During Ketamine Treatment: What to Discuss

If you have been prescribed ketamine, a brief record of symptoms and side effects can help you and your clinician review the plan. The purpose is to describe what is happening, including no change or unwanted changes. You do not need to search for signs that confirm a treatment is working.

Compounded ketamine is not FDA-approved. FDA has not reviewed compounded medications for safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric disorders. Compounded ketamine nasal spray is different from Spravato, the FDA-approved esketamine product used in certified healthcare settings.

Start with your own baseline

Before treatment, discuss which problems affect you most and how they influence everyday life. Choose a few concrete measures, such as completing routine tasks, staying connected with others, or managing symptoms during the day. Your clinician may also use a structured symptom questionnaire.

Keep the comparison practical. Record observations at similar times and distinguish the period of medication-related effects from your usual functioning. A single good day, a temporary sense of calm, or an unusual experience does not by itself establish a lasting treatment benefit.

What can you record?

• Mood and the severity of the symptoms you are treating.
• Sleep pattern, energy, appetite, and concentration.
• Ability to manage ordinary responsibilities and relationships.
• Side effects, when they occurred, and how they affected you.
• Other changes, such as stress, illness, or medication adjustments.

Short notes can help at follow-up. Ask how to contact your clinician about problems between visits.

Include changes that worry you

Report worsening symptoms, unusual agitation, markedly reduced need for sleep, or feeling unable to control medication use. Do not label every increase in energy as recovery. A clinician should assess unexpected changes rather than assuming they are a normal stage of treatment.

Ketamine-related detachment or altered perception is not proof of therapeutic progress. Likewise, the absence of an intense experience does not mean you should take more. Tell the clinician about distressing or unexpected effects before deciding what to do next.

What if there is little or no benefit?

Ask for a review of the diagnosis, treatment goals, adverse effects, and alternatives. There is no guaranteed response or universal timeline for compounded ketamine. Findings from intravenous ketamine or approved esketamine do not establish what to expect from your at-home formulation.

Use medication only as prescribed and do not change other treatments on your own. For severe symptoms, such as difficulty breathing or inability to wake someone, call 911. Routine email and follow-up appointments are not emergency services.

Risks and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Other concerns include abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems. A prescription or lower dose does not eliminate these risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Virtual follow-up does not provide the same monitoring as an onsite team. Discuss whether the setting is appropriate, your medication interactions, and an emergency plan before treatment.

Discuss your questions with a clinician

Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. If treatment is prescribed, an independent, appropriately licensed compounding pharmacy dispenses the medication. A consultation does not guarantee a prescription; applicable prescribing and compounding requirements must be met.

Book a Free Virtual Appointment or Follow-Up to review your questions, alternatives, and next steps. This article provides general education and does not replace individualized medical advice.

Further reading: NIMH: depression information; NIMH: medication follow-up and precautions; FDA: compounded-drug risks.